Your session is about to expire
← Back to Search
Colonoscopy Screening for Colorectal Cancer Risk in IBD
Study Summary
This trial will compare strategies for colorectal neoplasia screening in people with IBD, to see if one is better at finding cancerous lesions. 1952 participants needed.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had more than half of my colon removed.I am scheduled for a follow-up colonoscopy due to a recent cancer diagnosis.My colon inflammation is moderate to severe, affecting at least 25% of it, or mild but affecting at least 50%.I am 18 years old or older.I have had inflammatory bowel disease for 8 years or more, or I have it with primary sclerosing cholangitis.I am scheduled for or have had a full colon examination using special dye or virtual imaging.My last colonoscopy showed poor visibility even after cleaning.I am not experiencing symptoms at the time of my colonoscopy.I have a history of colorectal cancer.I am unable to understand and give consent for treatment.I am scheduled for a detailed colonoscopy using advanced imaging.My colonoscopy is mainly for cancer screening.My colonoscopy did not examine my entire colon.My ulcerative colitis or Crohn's disease affects more than just my rectum.Your Harvey-Bradshaw Index is below 541.
- Group 1: Experimental: Intervention Group
- Group 2: Control Group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this research endeavor accepting individuals older than thirty-five?
"This medical trial is searching for eligible participants who are within the age range of 18 to 100 years old."
Am I qualified to partake in this investigation?
"1952 participants with inflammatory bowel disease are needed for this research. Eligible individuals must be between 18 and 100 years of age to qualify."
What is the maximum enrollment capacity of this clinical trial?
"Yes, according to the information found on clinicaltrials.gov this trial is currently enrolling participants with recruitment commencing on September 23rd 2022 and last updated March 30th 2023. This medical experiment requires 1952 volunteers across 11 different sites."
Are there still vacancies within this investigation?
"Affirmative. According to clinicaltrials.gov, this examination is in the process of seeking volunteers. The trial was first posted on September 23rd 2022 and was most recently refreshed on March 30th 2023; it aims to enroll 1952 subjects at 11 different sites."
Could you please outline the number of healthcare facilities that are currently administering this trial?
"Currently, there are 11 sites recruiting for this trial including St. Paul's Hospital in Vancouver, University of Manitoba, Health Sciences Centre in Winnipeg and Eastern Regional Health Authority in St. John's as well as a handful of other medical centres."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger